Breaking
The 13 best cordless, upright and robot vacuums Focus groups: Deep anxiety about the economy drives undecided voters in two key Senate races 16-year-old girl runs on field and tackles football player mid-game, is charged with assault Harvard agrees to $53 million settlement over body parts stolen and sold by former morgue manager European playoffs: Rangers scrape first-leg win as Brighton draw in Norway How much could Trump's 'economic D-Day' hurt Iran? Brandon Flowers: Is fame worth it? I'm not sure anymore Tesla, Uber, and Waymo all get the OK to operate thousands of robotaxis in Nevada Charter plane carrying 8 crashes near remote radar site in western Alaska, NTSB says Anxiety over war, wildfires and cyber-attacks leads to growth in cash stocks in EU
NEWSREEL
The day, in 30-second reels.
--:--:--
Science / Reel
Science · Video brief

Ebola vaccine for Bundibugyo strain could take months before human trials

Researchers are working on vaccines for the Bundibugyo strain of Ebola, but human trials are months away. With no approved vaccines currently available, two candidates are being developed, though challenges remain. Health officials continue...

NBC News· May 20, 2026 · 11:31 PM · 27 views

Video won't play? Watch on YouTube →

Researchers are working on vaccines for the Bundibugyo strain of Ebola, but human trials are months away. With no approved vaccines currently available, two candidates are being developed, though challenges remain. Health officials continue to rely on traditional methods to control outbreaks. #Ebola #VaccineResearch #WHO #PublicHealth #EbolaOutbreak

Originally reported by NBC News. Read the full story →

More in Science

Science Scien
Science

Harvard agrees to $53 million settlement over body parts stolen and sold by former morgue manager

AP News· 1 hour ago
Science Scien
Science

What happens to people’s health when air pollution is reduced?

The Guardian· 1 hour ago
Science Scien
Science

‘Survival mode’: Indiana residents endure a ninth day without power

AP News· 8 hours ago

0 Comments

No comments yet. Be the first.